North Media A/S
Company announcement No 05-2021
19 February 2021
Pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse (as amended) persons discharging managerial responsibilities in North Media A/S and/or persons closely related with them must notify the Danish Financial Supervisory Authority and notify North Media A/S of transactions related to shares and/or linked financial instruments in North Media A/S.
North Media A/S hereby makes public pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse (as amended) the following information received from persons discharging managerial responsibilities in North Media A/S and/or persons closely related with them (see attached).
The transactions pertain to exercise of stock options:
Name | Holdings before transaction, no. of shares | Transaction, no. of shares | Holdings after transaction, no. of shares |
Henrik Løvig Jensen (acquisition) | 8,750 | 16,000 | 24,755 |
Jannik Bray Christensen (acquisition) | 0 | 16,000 | 16,000 |
For further information
Kåre Wigh, Group Executive Director & CFO, mobile +45 25 65 21 45
This document is an unofficial translation of the Danish original. In the event of any inconsistencies, the Danish version shall apply.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sampo plc17.10.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 16 October 2025
AM FRESH Group17.10.2025 07:00:00 CEST | Press release
AMFRESH Group Acquires 100% of TERRAMARA FRESH in Mexico, Strengthening Its Pacific Rim Farming Expansion
Standard Lithium17.10.2025 05:51:18 CEST | Press release
Standard Lithium Prices Upsized $130 Million Underwritten Public Offering
Junshi Biosciences17.10.2025 02:23:27 CEST | Press release
Junshi Biosciences Announces FDA’s Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients
Standard Lithium16.10.2025 22:22:32 CEST | Press release
Standard Lithium Announces Proposed Public Offering of Common Shares
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom